Celltrion outlines a blueprint for innovative drug development built on its antibody expertise The company highlights its business strategy to…
Read More
SHANGHAI, Jan. 13, 2026 /PRNewswire/ — ElpasBio Holdings (“ElpasBio”), a leading clinical-stage biotechnology company focused on regenerative medicine, today announced…
Read More